HEALTHCARE & MEDICARE
-
Rainfall Health raises $15M to help hospitals explore new CMS model
Rainfall Health’s Series A funding round was led by Two Bear Capital. The startup has raised a total of $18…
Read More » -
A proven approach to ensuring seamless CRM migration in highly regulated environments
Good organizations don't view migration as an IT activity. They view it as a compliance project that requires technical execution.…
Read More » -
Weaving a unified fabric of care will heal patient-provider relationships
Healthcare can only be transformed when strategy, workflow, data and relationships work together with a single purpose: to strengthen relationships…
Read More » -
What's the goal of Frist Cressey Ventures' $425 million health care fund?
Frist Cressey Ventures closed $425 million in its fourth fund, investing in early-stage healthcare companies using artificial intelligence to improve…
Read More » -
The difference integration makes in caring for dual eligibles
Nearly one in five Medicare enrollees is also enrolled in Medicaid. For these dual-eligible beneficiaries, Medicare serves as the primary…
Read More » -
Can we ride the GenAI wave without being overwhelmed by it? – Healthcare Blog
David Shewitz Lenin said: “There are decades when nothing happens; there are weeks when decades happen.” Maybe never. It’s also…
Read More » -
Maintaining clinician independence: Why simplicity, not integration, is the key to solving the mental health crisis
Rather than adding more complexity to an already strained system, there is a more effective solution: Make it simpler for…
Read More » -
Anthropic: Bringing company products into EHRs is 'vital'
When OpenAI launched ChatGPT Health to help consumers send their health and wellness questions directly to its now-ubiquitous bot, the…
Read More » -
Solera Health partners with Calm and Lyra to launch behavioral health network
Digital health services company Solera Health launched its new behavioral health network on Tuesday, with Calm Health and Lyra Health…
Read More » -
Eli Lilly joins the chase for hot inflammation target, spending $100 million for rights to CSL drug
Eli Lilly has been looking for drugs to follow the path blazed by its best-selling cardiometabolic drugs. The pharmaceutical company's…
Read More »